Expertise in
6
conditions

Rawi Hazzan

Safed, Z, IL 
Expertise in
6
conditions
Safed, Z, IL 

Overview

Rawi Hazzan practices practicing medicine in Safed, Israel.

Hazzan is highly rated in 6 conditions, according to our data. Their clinical expertise encompasses Hepatitis, Hepatitis D, Autoimmune Hepatitis, Colonoscopy, and Endoscopy.

They are actively involved in clinical research, co-authoring 52 peer reviewed articles and participating in 3 clinical trials.

Locations

Safed, Z, Israel
Other Locations
Ramat Gan, TA, Israel
Nazareth, Z, Israel
Afula, Z 18341, Israel
17662, Israel
Tel Aviv, TA, Israel
Haifa, HA, Israel

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Phase 3, Randomized, Open-Label, Parallel Arm Study to Evaluate the Efficacy and Safety of 180 mcg Peginterferon Lambda-1a (Lambda) Subcutaneous Injection for 48 Weeks in Patients With Chronic Hepatitis Delta Virus (HDV) Infection (LIMT-2)
Phase 3, Randomized, Open-Label, Parallel Arm Study to Evaluate the Efficacy and Safety of 180 mcg Peginterferon Lambda-1a (Lambda) Subcutaneous Injection for 48 Weeks in Patients With Chronic Hepatitis Delta Virus (HDV) Infection (LIMT-2)
Enrollment Status: Unknown
Publish Date: August 25, 2023
Intervention Type: Drug
Study Drug: Peginterferon Lambda-1a
Study Phase: Phase 3
A Phase 3, Matrix Design, Partially Double-Blind, Randomized Study of the Efficacy and Safety of 50 mg Lonafarnib/100 mg Ritonavir BID With and Without 180 mcg PEG IFN-alfa-2a for 48 Weeks Compared With PEG IFN-alfa-2a Monotherapy and Placebo Treatment in Patients Chronically Infected With Hepatitis Delta Virus Being Maintained on Anti-HBV Nucleos(t)Ide Therapy (D-LIVR)
A Phase 3, Matrix Design, Partially Double-Blind, Randomized Study of the Efficacy and Safety of 50 mg Lonafarnib/100 mg Ritonavir BID With and Without 180 mcg PEG IFN-alfa-2a for 48 Weeks Compared With PEG IFN-alfa-2a Monotherapy and Placebo Treatment in Patients Chronically Infected With Hepatitis Delta Virus Being Maintained on Anti-HBV Nucleos(t)Ide Therapy (D-LIVR)
Enrollment Status: Completed
Publish Date: April 14, 2023
Intervention Type: Drug
Study Drugs: Lonafarnib, Ritonavir, PEG IFN-alfa-2a
Study Phase: Phase 3
Characterization of Methylation Patterns in Hepatocellular Carcinoma
Characterization of Methylation Patterns in Hepatocellular Carcinoma
Enrollment Status: Terminated
Publish Date: May 06, 2021
Intervention Type: Procedure
View 2 Less Clinical Trials

52 Total Publications

The Impact of Achieving Sustained Viral Response with Direct Antiviral Agents in in HCV/HIV Co-infected Patients.
The Impact of Achieving Sustained Viral Response with Direct Antiviral Agents in in HCV/HIV Co-infected Patients.
Journal: The Israel Medical Association journal : IMAJ
Published: August 06, 2026

Frequently Asked Questions about Rawi Hazzan

Is Rawi Hazzan a top-rated expert for Hepatitis?

MediFind is an objective health platform that identifies experts based on real-world data. Rawi Hazzan is classified as an Advanced expert for Hepatitis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Rawi Hazzan participate in research or clinical trials?

Yes. Rawi Hazzan has published 52 articles and abstracts on conditions like Hepatitis. You can view a list of Rawi Hazzan's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Hazzan's expertise for a condition
ConditionClose
      View All 18 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile